The impact of p53 loss on murine plasmacytoma development

Chromosome Research

Volumn 10, Issue 3, 2002, Pages 239-251

  Mai, Sabine ^a   Wiener, Francis ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

c myc; p53; Plasmacytoma; Translocations

Indexed keywords

PROTEIN P53; CARCINOGEN; PRISTANE; TERPENE;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CHROMOSOME 15; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CYTOGENETICS; GENE LOCUS; LATENT PERIOD; MOUSE; MOUSE STRAIN; NONHUMAN; ONCOGENE C MYC; PLASMACYTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; CHROMOSOME PAINTING; CONGENIC STRAIN; GENE TRANSLOCATION; GENETICS; HETEROZYGOSITY LOSS; MOUSE MUTANT; ONCOGENE MYC;

ANIMAL; CARCINOGENS; CHROMOSOME PAINTING; GENES, MYC; GENES, P53; LOSS OF HETEROZYGOSITY; MICE; MICE, CONGENIC; MICE, INBRED BALB C; MICE, KNOCKOUT; PLASMACYTOMA; SUPPORT, NON-U.S. GOV'T; TERPENES; TRANSLOCATION (GENETICS); ANIMALS; TRANSLOCATION, GENETIC;

ANIMALIA; MURINAE;

EID: 0035986858     PISSN: 09673849     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015200307448     Document Type: Article

References (61)

1. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
2. Chromosome changes caused by alterations of p53 expression
3. Quantitation immunoelectrophoresis of serum proteins
4. c-myc/p53 interaction determines sensitivity of human colon carcinoma to fluorouracil in vitro and in vivo
5. The role of p53 in tumour suppression: Lesson from mouse models
6. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein
7. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: Contrasting effects of homozygous and heterozygous p53 loss
8. Immunofixation electrophoretic technique applied to identification of proteins in serum and cerebrospinal fluid
9. c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells
10. New reciprocal translocation
11. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
12. Disruption of the ARF-Mdm2-p53 tumor supressor pathway in Myc-induced lymphomagenesis
13. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice
14. Activation of c-myc oncogene by the immunoglobulin heavy-chain enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma
15. p53 is frequently mutated in Burkitt's lymphoma
16. Abnormal centrosome amplification in the absence of p53
17. Genomic instability and apoptosis are frequent in p53-deficient young mice
18. Frequent occurrence of deletions and duplications during somatic hypermutation: Implications for oncogene translocations and heavy chain disease
19. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors
20. Infrequent p53 mutation in mouse tumors with deregulated myc
21. p53 mutations in human cancers
22. Somatic point mutation in the p53 gene of human tumors and cell lines: Updated compilation
23. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis
24. Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival
25. Somatic hypermutation in normal and transformed human B cells
26. Accumulation of p53 protein correlates with tumour proliferative activity in EBV positive Burkitt's lymphoma
27. 6 Markers for chromosome studies in the mouse
28. p53, the cellular gatekeeper for growth and division
29. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
30. Overexpression of c-myc precedes amplification of the gene encoding dihydrofolate reductase
31. Murine FISH
32. c-Myc overexpression associated DHFR gene amplification in hamster, rat, mouse and human cell lines
33. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability
34. p53 in tumor progression: Life, death, and everything
35. Mutations in the p53 gene occurs in diverse human tumor types
36. Non-random chromosome changes involving the Ig-genes carrying chromosome 12 and 6 in pristane induced mouse plasmacytomas
37. Chromosomal translocation activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and Abelson virus
38. c-myc gene in a murine plasmacytoma without visible chromosomal translocation moves to chromosome 12F1 with Pvt-1 and rearranges with Ig-enhancer-S mu sequences
39. Murine plasmacytomas, carrier of the t(12;15) chromosomal translocation, develop from immature/mature B cells not from differentiated plasma cells
40. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas
41. Experimental plasmacytomagenesis in mice
42. Plasmacytomagenesis in mice: Model for neoplastic development dependent on chromosomal translocation
43. Upregulation of endogenous p53 and induction of in vivo apoptosis in B-lineage lymphomas of Eμ-myc transgenic mice by deregulated c-myc transgene
44. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia
45. Wild-type but not mutant p53 can repress transcription in vitro by interfering with the binding of basal transcription factors to the TATA motif
46. c-myc trans-activates the p53 promoter through a required downstream CACGTG motif
47. The mouse gene expression database
48. Immunofixation III. Application to the study of monclonal proteins
49. Mechanisms of p53 alteration in acute leukemias
50. Chromosome instability contributes to the loss of heterozygosity of mice lacking p53
51. Retroviral enhancer insertion 5′ myc in two translocation negative mouse plasmacytomas upregulate c-myc expression in different extent
52. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase
53. Biological activities of p53 in Burkitt lymphoma cells
54. A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice
55. Cytogenetic studies of IgA/lambda producing murine plasmacytomas: Regular occurrence of t(12;15) translocation
56. High resolution analysis of the involvement of strain BALB/c and AKR derived chromosome 15 in plasmacytoma specific translocation
57. The 'missing' mouse plasmacytoma (MPC) associated translocation T(15;16) occurs repeatedly in new MPC induction system
58. Nonrandom chromosomal change (Trisomy 11) in murine plasmacytomas induced by an ABL-MYC virus
59. Deregulated expression of c-Myc in a translocation negative plasmacytoma on extrachromosomal elements that carry IgH and myc-genes
60. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis
61. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles